Construction of an Innovative Nanogel and Its Applications for Achieving Chemo-Immunotherapy of Tumors
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c13445 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Sibei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Ti…. Hauptthemen laut MEDLINE: Immunotherapy, Nanogels, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
Malignant tumors, also known as cancers, are a global public health problem. Nanogels are promising carriers for the delivery of anticancer medicines. Therefore, based on the unique microenvironment of tumor cells and the advantages of nanogels, a simple and economical one-pot synthesis method was designed to construct natural polysaccharide-based redox-responsive nanogels (LDD NGs). The enhanced permeability and retention (EPR) effect enriched LDD NGs in tumor cells, which then rapidly collapsed and released the natural antitumor drug diosgenin (DG) and the natural polysaccharide lentinan (LNT) via the depletion of a high level of reduced glutathione (GSH) in tumor cells, resulting in a synergistic therapeutic effect of chemotherapy and immunotherapy. In vivo antitumor experiments showed that LDD NGs could inhibit the proliferation and metastasis of the A549 lung cancer cells. Further studies indicated that LDD NGs could increase the production of ROS and induce apoptosis of A549 cells. In addition, LNT released from LDD NGs could promote the proliferation of dendritic cells, increase the production of NO, and upregulate the expressions of the costimulatory molecules CD40, CD80, CD86, and MHC-II. The construction of LDD NGs was a novel drug synthesis approach that could provide fresh ideas for the development of polysaccharide-based redox-responsive drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China.
ORCID-Profile: Sibei Wang, Zhen Lin, Jing Xu, Yuanqiang Guo
Förderung
- National Natural Science Foundation of China
- Higher Education Discipline Innovation Project
Zitieren
APA
Wang, S., Nie, F., Lin, Z., Cao, R., Xu, J., & Guo, Y. (2024). Construction of an Innovative Nanogel and Its Applications for Achieving Chemo-Immunotherapy of Tumors. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c13445
Vancouver
Wang S, Nie F, Lin Z, Cao R, Xu J, Guo Y. Construction of an Innovative Nanogel and Its Applications for Achieving Chemo-Immunotherapy of Tumors. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c13445
BibTeX
@article{Wang2024,
author = {Wang, Sibei and Nie, Fan and Lin, Zhen and Cao, Ruyu and Xu, Jing and Guo, Yuanqiang},
title = {Construction of an Innovative Nanogel and Its Applications for Achieving Chemo-Immunotherapy of Tumors},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c13445}
}
EUVIMED